Navigation Links
Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
Date:5/7/2009

p>

Research and development expenses for the first quarter of 2009 were $11.4 million, compared to $21.2 million for the first quarter of 2008. Reduced expenses in the first quarter of 2009 reflect Jazz Pharmaceuticals' decision that its JZP-4, JZP7, and JZP-8 programs will continue to the next phase of development only upon partnering or other funding for the programs.

Selling, general and administrative expenses for the first quarter of 2009 were $14.2 million, compared to $32.8 million for the first quarter of 2008. The decrease in the first quarter of 2009 reflects a decrease in spending on Luvox CR and the 2008 reductions in force.

Jazz Pharmaceuticals' net loss for the first quarter of 2009 was $13.0 million, compared to a net loss of $46.7 million for the first quarter of 2008.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information see www.JazzPharmaceuticals.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including, but not limited to, statements related to future product sales, the results of the second pivotal trial for JZP-6 and the timing thereof, the planned submission of an NDA and the timing thereof, and potential partnering arrangements for certain of the company's programs. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...position promotes self-assurance, research finds ,...ur mother may have been right when she told you to...posture could make you feel more confident about y...itting up straight gives a good impression to othe...nd a psychology professor at Ohio State University...
(Date:11/8/2009)...ushing Taxes Nail Nation,s Job Creators ,, WASH...nse to U.S. House passage of the health care bill ... Council (SBE Council) president & CEO Karen K...ke no mistake, those voting for H.R. 3962 voted to...s and crushing taxes and penalties. Even in the be...
(Date:11/8/2009)... New book called "Preventing and Healing AIDS...iraldo shows that AIDS is a result of multiple, re...led immune system stressor agents, which can be ei...ll, emotional. , Oakland...h; 8, 2009, cell biologists, physicians, chemists ...
(Date:11/8/2009)... Men’s Health Network (MHN) urges military v...lly those linked to exposure to chemicals, atomic ...adder cancer is one of those cancers that is two t...who once smoked or currently smoke cigarettes. , ...mber 8, 2009 -- Men’s Health Network (MHN) k...
(Date:11/8/2009)...not mean the battle is won," said Dr. Charmaine Yo...ire/ -- In a vote of 240-194, the Stupak-Ellsworth...to prohibit abortion mandates and funding in HR 39...ed for Life Action President and CEO Dr. Charmaine...ictory for the pro-life Americans across this coun...
Breaking Medicine News(10 mins):Health News:Good Posture May Inspire Confidence 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
...s success in tracking medications, reducing worklo... -- An interactive voice system makes it easier fo... warfarin or other blood thinners, a Canadian stud...al. But, this type of monitoring is labor intensi...
...newly diagnosed with hypertension, diabetes or hig...ay initiating recommended drug treatment if they f...to a new RAND Corporation study. , The delay was ...blished in the April 27 edition of the Archives o...
...studies have shown that depression is associated w...y how has never been clear. , Now, researchers at...pression is linked with the accumulation of viscer...diabetes. , The study is posted online and will b...
... utilizes Phreesia,s electronic patient check-in s...EW YORK, April 28 Phreesia, the Patient Check-In ...w risk assessment tool in its electronic patient i...ewscom.com/cgi-bin/prnh/20090428/NY06275 ) , (L...
...IA, April 28 "The ABIM Foundation both lauds and ...lict of Interest in Medical Research, Education, a...l to protecting the integrity of professional judg...eration of Internal Medicine recognized that physi...
...April 28 Individuals who may have overpaid for ce...to get money back from a class action settlement. ...e the details. , , Listen to this report from the...nalists can access video, audio, text, graphics an...
Other Medicine News:Health News:Automated Calls May Help Doctors Monitor Patients 2Health News:Study finds higher drug co-pays discourage patients from starting treatment 2Health News:Depression linked with accumulation of visceral fat 2Health News:Phreesia Works With Osteoporosis Experts to Expand its Measurement Guided Care Program 2Health News:Phreesia Works With Osteoporosis Experts to Expand its Measurement Guided Care Program 3Health News:Statement by Christine K. Cassel, MD, President and CEO of the ABIM Foundation on the Institute of Medicine Report: Conflict of Interest in Medical Research, Education, and Practice 2
(Date:11/6/2009)...swire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (...reviously approved reverse split of its common sto...day, Nov. 9, 2009 on a 1-for-15 split-adjusted bas... under the new symbol OXBT. The stock also will ha... becomes effective. ,, "This reverse split was ...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Watson Pharmaceuticals, In...al company, announced today that Paul Bisaro, Wats...rovide an overview and update of the Company,s bus...Conference on Wednesday, November 11, 2009 at 12:0...n will be webcast live and can be accessed on Wats...
(Date:11/6/2009)... The ,Help is Here Expre...d Georgia throughout the week of November 9-13 at ...ncially-struggling patients access information on ...ree or nearly free. With the nation,s unemployment...r Prescription Assistance (PPA) bus tour is raisin...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3National Medical Association Applauds President Obamas and Senator Baucuss Efforts to Work With PhRMA to Bring Down Health Care Costs and Advance Mean 49834 1US Oncology Offers Electronic Health Records Informative Webinar 49831 1US Oncology Offers Electronic Health Records Informative Webinar 49831 2US Oncology Offers Electronic Health Records Informative Webinar 49831 3Symmetry Medical Appoints Chairman and Two Directors 49828 1Symmetry Medical Appoints Chairman and Two Directors 49828 2Symmetry Medical Appoints Chairman and Two Directors 49828 3Symmetry Medical Appoints Chairman and Two Directors 49828 4
...ower Instrument System is a small power instrument...th modular and unitized handpieces.,The head modu...tic motor, giving you the flexibility of having tw...add instruments to your system just by purchasing ...
Powermaster Oscillating Saw
Large Power Battery/Electric Oscillating Saw
...of a pistol-grip handpiece available in Pneumatic,...couplers that can be used in a variety of orthoped...er XT offers significantly increased torque and sp...The Battery SmartDriver XT accepts the full line o...
Medicine Products: